Upstream Bio, Inc. (UPB)
29.86
+1.53
(+5.40%)
USD |
NASDAQ |
Dec 18, 16:00
29.78
-0.08
(-0.27%)
Pre-Market: 20:00
Upstream Bio EPS Diluted (Quarterly): -0.6258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.75M |
| Revenue (Quarterly) | 0.683M |
| Total Expenses (Quarterly) | 34.43M |
| Enterprise Value | 1.239B |
| Gross Profit Margin (Quarterly) | 95.46% |
| Profit Margin (Quarterly) | -4.94K% |
| Earnings Yield | -7.65% |
| Normalized Earnings Yield | -7.649 |